Tag: ERHER2
Sanofi provides an update on the phase II study evaluating amcenestrant in the treatment of advanced or metastatic ER+/HER2- breast cancer – 03/14/2022 at 07:00
Sanofi takes stock of the phase II study evaluating the amcenestrant in the treatment of breast cancer ER+/HER2- at an advanced or metastatic stage The AMEERA-3 trial failed to meet…